Market Tracker

05/30 12:30pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.33
Delayed Data
As of May 27
 +0.16 / +3.84%
Today’s Change
2.96
Today|||52-Week Range
29.94
-72.39%
Year-to-Date
3 Reasons Celldex Therapeutics Stock Could Rise
May 23 / MotleyFool.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
3 Healthcare Stocks Bears Are Wrong About
May 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close4.17
Today’s open4.17
Day’s range4.09 - 4.34
Volume1,449,548
Average volume (3 months)3,993,356
Market cap$427.5M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)-1.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.47

Competitors

 Today’s
change
Today’s
% change
UBICUBIC Inc0.000.00%
MGMistras Group Inc+0.06+0.24%
FCSCFibrocell Science In...+0.04+1.91%
RNVARennova Health Inc0.000.00%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts